CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
I-STRONG for SCDbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06110754
NCT06110754N/ACompleted

Integrative Training Program for Pediatric Sickle Cell Pain (I-STRONG for SCD): Optimizing Feasibility and Acceptability

Emory University·interventional·Posted Nov 1, 2023·Updated Dec 19, 2025

In Brief

A clinical study evaluating I-STRONG for SCD for Sickle Cell Disease. Completed, enrolled 45 participants across 2 sites.

Detailed Summary

This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedNov 1, 2023
Enrollment StartJun 8, 2023
Primary CompletionJun 14, 2024
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 2.7 years ago

Interventions

I-STRONG for SCDbehavioral

I-STRONG for SCD is a group-based, multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training. The intervention includes 16 sessions that occur over 8 weeks. Adolescents attend every session and parents attend 6 of the 16 sessions.